Shortlist by what you need
Start here if you know why you are leaving Qureight.
Want the closest match?
RayscapeMost similar to Qureight in what it does, its category and its price.
Visit (opens Rayscape in a new tab)Want the best rated?
ProsciaRated 4.3 out of 5 in our review, against 4.1 for Qureight.
Visit (opens Proscia in a new tab)
At a glance
Green means better than Qureight, red means worse. Prices are starting prices per month.
| Tool | Our rating | Starts at | Free plan | Best for | Compare |
|---|---|---|---|---|---|
 QureightBaseline | 4.1 | Not listed | No | Imaging biomarkers for lung and heart clinical trials, from a Cambridge deep-learning lab. | |
| Rayscape | 3.7−0.4 | Not listed | No | FDA-cleared AI that reads chest X-rays and lung CTs for 148+ pathologies, trained on 42M+ medical images - detects, measures, and tracks pulmonary nodules from 3 to 30mm. | vs Qureight |
 Enlitic | 3.9−0.2 | Not listed | No | Deep-learning chest X-ray analysis (CXR-AI) sped radiologist interpretation over 20% in early trials - the first U.S. imaging AI company approved to commercialize in Japan. | vs Qureight |
| Proscia | 4.3+0.2 | Not listed | No | FDA-cleared digital pathology platform for primary diagnosis and biomarker research. | vs Qureight |
 Unlearn.AI | 4.2+0.1 | Not listed | No | Digital twins of trial participants that shrink the control arm by about a third. | vs Qureight |
 RetinAI | 4.1Same | Not listed | No | CE-marked retinal imaging analysis for clinics, trials and pharmaceutical research. | vs Qureight |
 QuantHealth | 4.1Same | Not listed | No | Clinical trial simulation platform for predicting patient response to therapies | vs Qureight |
 Paige | 4.1Same | Not listed | No | Digital pathology AI co-pilot from Memorial Sloan Kettering researchers, acquired by Tempus in 2025 | vs Qureight |
 NeuroClues | 4.3+0.2 | Not listed | No | Eye-tracking medical device that uses AI to detect early biomarkers of Parkinson's, Alzheimer's, and multiple sclerosis. | vs Qureight |
The alternatives in detail
In order of how closely each one matches Qureight.
Rayscape
3.7Not listed
vs Qureight−0.4
FDA-cleared AI that reads chest X-rays and lung CTs for 148+ pathologies, trained on 42M+ medical images - detects, measures, and tracks pulmonary nodules from 3 to 30mm.
- 148+ pathology detection on chest X-rays
- Pulmonary nodule detection, measurement, and tracking on lung CT
- Multiple FDA clearances and extensive clinical validation
Genuine regulatory clearance (FDA) rather than just a marketing claim
Pricing isn't public - requires direct institutional engagement
Enlitic
3.9Not listed
vs Qureight−0.2
Deep-learning chest X-ray analysis (CXR-AI) sped radiologist interpretation over 20% in early trials - the first U.S. imaging AI company approved to commercialize in Japan.
- CXR-AI - deep-learning chest X-ray abnormality detection
- ENDEX - AI-based medical image data standardization
- Curie platform for real-world evidence data infrastructure
Regulatory approval (Japan) is a concrete, third-party-verifiable claim
Enterprise healthcare infrastructure - not accessible to individual practitioners or consumers
Proscia
4.3Not listed
vs Qureight+0.2
FDA-cleared digital pathology platform for primary diagnosis and biomarker research.
- FDA-cleared for primary clinical diagnosis in AP-Dx
- Concentriq AP, AP-Dx and LS configurations
- Biomarker research and clinical trial workflows
FDA clearance for primary diagnosis, not just research viewing
No published pricing
Unlearn.AI
4.2Not listed
vs Qureight+0.1
Digital twins of trial participants that shrink the control arm by about a third.
- Digital twins forecasting participant outcomes
- Control arm size reduction of around 33 percent
- Scout for literature and regulatory search
Fewer control participants is an ethical gain as well as a commercial one
No published pricing
RetinAI
4.1Not listed
vs QureightSame
CE-marked retinal imaging analysis for clinics, trials and pharmaceutical research.
- OCT Atlas CE-marked for AMD, DR, DME and glaucoma
- LuxIA CE-MDR certified for diabetic retinopathy screening
- Discovery UNITY for unified imaging data
CE marking separates it from research-only imaging tools
No published pricing
QuantHealth
4.1Not listed
vs QureightSame
Clinical trial simulation platform for predicting patient response to therapies.
- In-silico simulation of clinical trial outcomes
- Patient response prediction across therapy candidates
- Protocol testing before a trial is committed
Tests expensive protocol decisions before commitment
Credibility depends on retrospective validation in the same indication
Paige
4.1Not listed
vs QureightSame
Digital pathology AI co-pilot from Memorial Sloan Kettering researchers, acquired by Tempus in 2025.
- Paige Alba AI co-pilot for digital pathology tissue-slide analysis
- Cancer diagnosis, tissue subtyping, and molecular biomarker discovery support
- Founded in 2017 by researchers from Memorial Sloan Kettering Cancer Center
Research pedigree from Memorial Sloan Kettering lends real clinical credibility
Enterprise-only pricing requires a sales conversation before evaluation
NeuroClues
4.3Not listed
vs Qureight+0.2
Eye-tracking medical device that uses AI to detect early biomarkers of Parkinson's, Alzheimer's, and multiple sclerosis.
- Portable, CE-marked Class IIa medical device for clinical eye-movement recording
- Calibration-free patient setup using dual infrared cameras at 400 fps
- AI-derived biomarkers benchmarked against reference ranges for clinical interpretation
CE-marked Class IIa medical device status gives it real regulatory clearance, not only research-stage promise
No published pricing, and as a clinical device it is sold directly to institutions, not individuals
FAQ
Questions people ask
Is Qureight free?
Qureight does not list a free plan. Check its pricing page for current plans.
How did you pick these alternatives?
We match tools on what they do, their category and their price, using the details in our directory. Ratings come from our reviews and reader reviews.